154 related articles for article (PubMed ID: 37865587)
1. Barriers to and Facilitators of Implementing Guidelines for Detecting Familial Hypercholesterolaemia in Australia.
Sarkies MN; Testa L; Best S; Moullin JC; Sullivan D; Bishop W; Kostner K; Clifton P; Hare D; Brett T; Hutchinson K; Black A; Braithwaite J; Nicholls SJ; Kangaharan N; Pang J; Abhayaratna W; Horton A; Watts GF
Heart Lung Circ; 2023 Nov; 32(11):1347-1353. PubMed ID: 37865587
[TBL] [Abstract][Full Text] [Related]
2. Screening for hypercholesterolaemia versus case finding for familial hypercholesterolaemia: a systematic review and cost-effectiveness analysis.
Marks D; Wonderling D; Thorogood M; Lambert H; Humphries SE; Neil HA
Health Technol Assess; 2000; 4(29):1-123. PubMed ID: 11109029
[TBL] [Abstract][Full Text] [Related]
3. International Atherosclerosis Society guidance for implementing best practice in the care of familial hypercholesterolaemia.
Watts GF; Gidding SS; Hegele RA; Raal FJ; Sturm AC; Jones LK; Sarkies MN; Al-Rasadi K; Blom DJ; Daccord M; de Ferranti SD; Folco E; Libby P; Mata P; Nawawi HM; Ramaswami U; Ray KK; Stefanutti C; Yamashita S; Pang J; Thompson GR; Santos RD
Nat Rev Cardiol; 2023 Dec; 20(12):845-869. PubMed ID: 37322181
[TBL] [Abstract][Full Text] [Related]
4. Using implementation science to develop a familial hypercholesterolemia screening program in primary care: The CARE-FH study.
Jones LK; Romagnoli KM; Schubert TJ; Clegg K; Kirchner HL; Hu Y; Cawley D; Norelli V; Williams MS; Gidding SS; Rahm AK
J Clin Lipidol; 2024; 18(2):e176-e188. PubMed ID: 38228467
[TBL] [Abstract][Full Text] [Related]
5. Detection and management of familial hypercholesterolaemia in primary care in Australia: protocol for a pragmatic cluster intervention study with pre-post intervention comparisons.
Arnold-Reed DE; Brett T; Troeung L; Vickery A; Garton-Smith J; Bell D; Pang J; Grace T; Bulsara C; Li I; Bulsara M; Watts GF
BMJ Open; 2017 Oct; 7(10):e017539. PubMed ID: 29061621
[TBL] [Abstract][Full Text] [Related]
6. Improving the detection of familial hypercholesterolaemia.
Lan NSR; Martin AC; Brett T; Watts GF; Bell DA
Pathology; 2019 Feb; 51(2):213-221. PubMed ID: 30579649
[TBL] [Abstract][Full Text] [Related]
7. Implementation of a primary-tertiary shared care model to improve the detection of familial hypercholesterolaemia (FH): a mixed methods pre-post implementation study protocol.
Birkenhead K; Sullivan D; Trumble C; Spinks C; Srinivasan S; Partington A; Elias L; Hespe CM; Fleming G; Li S; Calder M; Robertson E; Trent R; Sarkies MN
BMJ Open; 2024 May; 14(5):e082699. PubMed ID: 38692720
[TBL] [Abstract][Full Text] [Related]
8. Progress in the care of familial hypercholesterolaemia: 2016.
Bell DA; Watts GF
Med J Aust; 2016 Sep; 205(5):232-6. PubMed ID: 27581271
[TBL] [Abstract][Full Text] [Related]
9. Detecting familial hypercholesterolaemia in general practice.
Kirke A; Watts GF; Emery J
Aust Fam Physician; 2012 Dec; 41(12):965-8. PubMed ID: 23210121
[TBL] [Abstract][Full Text] [Related]
10. International Atherosclerosis Society Roadmap for Familial Hypercholesterolaemia.
Watts GF; Jones LK; Sarkies MN; Pang J; Gidding SS; Libby P; Santos RD
Glob Heart; 2024; 19(1):12. PubMed ID: 38273993
[TBL] [Abstract][Full Text] [Related]
11. Awareness of familial hypercholesterolaemia in Australian primary care: A qualitative descriptive study.
Bulsara C; Brett T; Radford J; Heal C; Gill G; Hespe CM; Vargas-Garcia C; Li IW; Sullivan DR; Vickery AW; Pang J; Arnold-Reed D; Chan DC; Watts GF
Aust J Gen Pract; 2021 Sep; 50(9):634-640. PubMed ID: 34462767
[TBL] [Abstract][Full Text] [Related]
12. Establishing a national screening programme for familial hypercholesterolaemia in Lithuania.
Petrulioniene Z; Gargalskaite U; Kutkiene S; Staigyte J; Cerkauskiene R; Laucevicius A
Atherosclerosis; 2018 Oct; 277():407-412. PubMed ID: 30270078
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of genetic cascade screening for familial hypercholesterolaemia using a centrally co-ordinated clinical service: an Australian experience.
Bell DA; Pang J; Burrows S; Bates TR; van Bockxmeer FM; Hooper AJ; O'Leary P; Burnett JR; Watts GF
Atherosclerosis; 2015 Mar; 239(1):93-100. PubMed ID: 25585028
[TBL] [Abstract][Full Text] [Related]
14. Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: Rationale and design of the global EAS Familial Hypercholesterolaemia Studies Collaboration.
; Vallejo-Vaz AJ; Akram A; Kondapally Seshasai SR; Cole D; Watts GF; Hovingh GK; Kastelein JJ; Mata P; Raal FJ; Santos RD; Soran H; Freiberger T; Abifadel M; Aguilar-Salinas CA; Alnouri F; Alonso R; Al-Rasadi K; Banach M; Bogsrud MP; Bourbon M; Bruckert E; Car J; Ceska R; Corral P; Descamps O; Dieplinger H; Do CT; Durst R; Ezhov MV; Fras Z; Gaita D; Gaspar IM; Genest J; Harada-Shiba M; Jiang L; Kayikcioglu M; Lam CS; Latkovskis G; Laufs U; Liberopoulos E; Lin J; Lin N; Maher V; Majano N; Marais AD; März W; Mirrakhimov E; Miserez AR; Mitchenko O; Nawawi H; Nilsson L; Nordestgaard BG; Paragh G; Petrulioniene Z; Pojskic B; Reiner Ž; Sahebkar A; Santos LE; Schunkert H; Shehab A; Slimane MN; Stoll M; Su TC; Susekov A; Tilney M; Tomlinson B; Tselepis AD; Vohnout B; Widén E; Yamashita S; Catapano AL; Ray KK
Atheroscler Suppl; 2016 Dec; 22():1-32. PubMed ID: 27939304
[TBL] [Abstract][Full Text] [Related]
15. Integrated Guidance for Enhancing the Care of Familial Hypercholesterolaemia in Australia.
Watts GF; Sullivan DR; Hare DL; Kostner KM; Horton AE; Bell DA; Brett T; Trent RJ; Poplawski NK; Martin AC; Srinivasan S; Justo RN; Chow CK; Pang J;
Heart Lung Circ; 2021 Mar; 30(3):324-349. PubMed ID: 33309206
[TBL] [Abstract][Full Text] [Related]
16. Family cascade screening for equitable identification of familial hypercholesterolemia: study protocol for a hybrid effectiveness-implementation type III randomized controlled trial.
Johnson C; Chen J; McGowan MP; Tricou E; Card M; Pettit AR; Klaiman T; Rader DJ; Volpp KG; Beidas RS
Implement Sci; 2024 Apr; 19(1):30. PubMed ID: 38594685
[TBL] [Abstract][Full Text] [Related]
17. How do the experiences and beliefs of adults and children with heterozygous familial hypercholesterolaemia influence their adherence to treatment? A systematic review of qualitative evidence protocol.
Kinnear FJ; Perry R; Searle A; Hamilton-Shield JP; Lithander FE
Syst Rev; 2018 Aug; 7(1):120. PubMed ID: 30111381
[TBL] [Abstract][Full Text] [Related]
18. Participant experiences of intervention to detect and manage familial hypercholesterolaemia in Australian general practice: A qualitative descriptive study.
Skoss R; Brett T; Bulsara C; Radford J; Heal C; Gill G; Hespe C; Vargas-Garcia C; Li IW; Sullivan DR; Vickery AW; Pang J; Arnold-Reed DE; Watts GF
Aust J Gen Pract; 2022 Sep; 51(9):687-694. PubMed ID: 36045626
[TBL] [Abstract][Full Text] [Related]
19. An enquiry based on a standardised questionnaire into knowledge, awareness and preferences concerning the care of familial hypercholesterolaemia among primary care physicians in the Asia-Pacific region: the "Ten Countries Study".
Pang J; Hu M; Lin J; Miida T; Nawawi HM; Park JE; Wu X; Ramli AS; Kim NT; Kwok S; Gonzalez-Santos LE; Su TC; Truong TH; Soran H; Yamashita S; Tomlinson B; Watts GF
BMJ Open; 2017 Oct; 7(10):e017817. PubMed ID: 29074516
[TBL] [Abstract][Full Text] [Related]
20. Reaching detection targets in familial hypercholesterolaemia: Comparison of identification strategies.
Wald DS; Bestwick JP
Atherosclerosis; 2020 Jan; 293():57-61. PubMed ID: 31837509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
